The concentration of soluble interleukin 2 receptor (IL-2R) was determined in the serum of 54 patients with systemic lupus erythematosus (SLE) by an enzyme linked immunosorbent assay (ELISA) using two monoclonal antibodies with the IL-2R. Concentrations of soluble IL-2R in the serum of the patients with SLE (study group) were significantly higher than in 20 normal subjects (control group). The relation between concentrations of soluble IL-2R and clinical findings was investigated. The concentration of soluble IL-2R showed no particular relation with the clinical manifestations and did not correlate with the level of anti-DNA antibody or CH50. Significant correlation between the concentration of soluble IL-2R and disease activity did exist, however. Furthermore, the concentration of soluble IL-2R in some cases changed simultaneously with the disease activity. Thus the concentration of soluble IL-2R may serve as a new clinical indicator of disease activity in patients with SLE.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Tokano, Y., Murashima, A., Takasaki, Y., Hashimoto, H., Okumura, K., & Hirose, S. (1989). Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases, 48(10), 803–809. https://doi.org/10.1136/ard.48.10.803